ESR1 and breast cancer: We analyzed 2,509 breast cancers in “cBioportal” and 3,063 breast cancer data in “bc-GenExMiner,” respectively, and got the following conclusion: high expression of DNA2 was closely correlated with ER-, PR-, and HER2+, indicating worse prognosis and therapy effect in breast cancer.